1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Colorectal cancer

Immunoscore for predicting risk of colon cancer relapse

Medtech innovation briefing [MIB269] Published: 03 August 2021

  • Overview
  • Summary
  • The technology
  • Regulatory information
  • Equality considerations
  • Clinical and technical evidence
  • Expert comments
  • Expert commentators
  • Development of this briefing
Download (PDF)

Advice

  • Next

NICE has developed a medtech innovation briefing on Immunoscore for predicting risk of colon cancer relapse.

What are MIBS?


  • Next